| Apr 15, 2025 | — | Common Questions About Buprenorphine Treatment for Opioid Use Disorder |
| Nov 15, 2023 | — | Prescribing Opioids for Pain: Guidelines From the Centers for Disease Control and Prevention [Practice Guidelines] |
| Feb 13, 2023 | — | Opioid Epidemic Updates: “Frankenstein Opioids” and Xylazine-Induced Skin Ulcers |
| Jul 01, 2020 | — | Family Physicians Play Key Role in Bridging the Gap in Access to Opioid Use Disorder Treatment [Graham Center Policy One-Pager] |
| Oct 01, 2019 | — | Opioid Use Disorder: Medical Treatment Options |
| Mar 15, 2019 | — | Lofexidine (Lucemyra) for Treatment of Opioid Withdrawal Symptoms [STEPS] |
| May 15, 2018 | — | Implantable Buprenorphine (Probuphine) for Maintenance Treatment of Opioid Use Disorder [STEPS] |
| Apr 01, 2017 | — | Management of Chronic Pain and Opioid Misuse: A Position Paper from the AAFP [Practice Guidelines] |
| Sep 15, 2023 | — | The Role of Xylazine in the Overdose Crisis [Editorials] |
| Oct 01, 2019 | — | Common Misperceptions About Buprenorphine Prescribing for Opioid Use Disorder [Editorials] |
| Mar 01, 2018 | — | Treating Opioid Use Disorder as a Family Physician: Taking the Next Step [Editorials] |
| Sep 15, 2017 | — | How Family Physicians Can Combat the Opioid Epidemic [Editorials] |
| Apr 01, 2017 | — | Chronic Pain Management and Opioid Misuse: Guidance for Family Physicians [Editorials] |